Biogen Reports a 6% Revenue Increase to $2.4 Billion in Q1 2025, Highlighting Strategic Growth
Biogen Inc. reported a 6% increase in Q1 2025 revenue to $2.4 billion, despite a drop in GAAP diluted EPS to $1.64. CEO Christopher Viehbacher highlights the strategic growth and d...